Journal of Biological Chemistry
Volume 274, Issue 40, 1 October 1999, Pages 28505-28513
Journal home page for Journal of Biological Chemistry

CELL BIOLOGY AND METABOLISM
Fas-induced Apoptosis in Human Malignant Melanoma Cell Lines Is Associated with the Activation of the p34cdc2-related PITSLRE Protein Kinases*

https://doi.org/10.1074/jbc.274.40.28505Get rights and content
Under a Creative Commons license
open access

The Cdc2L locus encoding the PITSLRE protein kinases maps to chromosome band 1p36 and consists of two duplicated and tandemly linked genes. The purpose of the present study was to determine whether diminution of PITSLRE kinases leads to deregulation of apoptosis. The human melanoma cell lines A375 (Cdc2L wild-type alleles) and UACC 1227 (mutant Cdc2L alleles) were tested with agonist anti-Fas monoclonal antibody. We found that exposure of these cells to anti-Fas for 24, 48, or 72 h resulted in differential sensitivity to Fas-induced apoptosis. In A375, cell death started at 24–48 h post-treatment, and it was maximal by 72 h. Conversely, UACC 1227 cells were resistant to Fas-mediated apoptosis. Induction of PITSLRE histone H1 kinase activity was observed in A375 anti-Fas treated but not in UACC 1227 cells. Also, the PITSLRE protein kinase activity in A375 anti-Fas-treated cells preceded maximal levels of apoptosis. Finally, fluorescence confocal microscopy revealed a nuclear localization of PITSLRE proteins in normal melanocytes and A375 cells but a cytoplasmic localization in UACC 1227 cells. The differences in PITSLRE protein and cellular localization between A375 and UACC 1227 cells appear to account for the differences in sensitivity of the two cells lines to anti-Fas and staurosporine. These observations suggest that alterations in PITSLRE gene expression and protein localization may result in the loss of apoptotic signaling.

Cited by (0)

*

This research was supported by a grant from National Institutes of Health (R29-CA 70145–01), by the friends of the Arizona Cancer Center, by a grant from National Institutes of Health (GM44088) (to V. J. K.) and by the SWEHSC Core Grant P30ES06694.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.